Cite
MLA Citation
E E Vokes et al.. “Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.” Annals of oncology, vol. 29, 2018, pp. 959–965. http://access.bl.uk/ark:/81055/vdc_100097078968.0x00001d